skip to Main Content
 

AIM round-up: Netscientific, Filtronic, Alien Metals

*

London’s AIM Index was rangebound through Monday’s session, although managed to tack on some wafer-thin gains in the last hour of trade to reach the bell less than one point higher at 1257.68.

  • Netscientific +92%
  • Filtronic +17%
  • Univision Engineering -21%
  • Kropz -12%
  • Alien Metals +3%

Netscientific [LON: NSCI] saw its shares move 90% higher today in the wake of news that a wholly owned portfolio company – ProAxis – has entered into an exclusive licensing agreement with AstraZeneca. This relates to a new COVID-19 therapy and clearly and although full validation remains necessary, this should be possible from existing resources.


Filtronic [LON:FTC] added 17%, making it the day’s second biggest riser by the closing bell. The company has seen research coverage initiated by Edison, which has the potential to provide a higher profile for the stock and its associated investment opportunity.

Univision Engineering [LON:UVEL] was the day’s worst performer, off 21% by 4.30pm following an update this morning. The company had advised that its Chairman had expected to sell a majority holding to a Singaporean investment vehicle. This option has however now lapsed – there’s no detail as to what triggered the collapse of the deal, but investors are understandably disappointed.

Kropz [LON:KRPZ] also struggled today, shedding 12% although trade was thin and the spread remarkably wide. A note this morning advised that there would be a delay in publishing accounts, meaning they cannot be tabled for acceptance at the forthcoming AGM. The stock has however been making gains over the last couple of months – even after today’s adjustment lower the mid-price is still well above levels seen a couple of months ago.

A notable mention for Alien Metals [LON:UFO] who this morning issued a robust drilling report. Expectations had been that a more dramatic bounce in the share price may have followed, but instead the stock spent much of the day struggling to find a way ahead despite elevated levels of interest, reaching the bell some 3% higher.

Like this article? Sign up to our free newsletter.

This article does not constitute investment advice. Do your own research or consult a professional advisor.

The Armchair Trader's 'How to' Guides

In-depth Reports

Detailed reviews of selected companies and investment trusts.

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
FP Markets
IG
Pepperstone
WisdomTree
Back To Top